SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is trending following a massive 20-year data center lease with Anthropic that is projected to generate $19 billion in revenue, fueling intense community debate over whether this validates the company's AI infrastructure pivot or if current price action remains distorted by short-term market volatility and manipulation. Investors are actively discussing the stock's transition from a Bitcoin mining proxy to a major compute provider, while weighing the significance of the Anthropic deal against broader sector headwinds and recent stock price fluctuations.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is trending as investors eye a potential short squeeze, fueled by high short interest and anticipation surrounding its expansion into the telecom and energy sectors. The community is closely watching the stock's ability to hold above key resistance levels as market sentiment shifts toward AI-driven enterprise solutions.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell Technologies is currently generating significant market chatter driven by a policy-focused narrative, with investors closely watching the company following recent high-profile mentions by President Trump regarding personal stock holdings and potential government-related investment accounts. While bullish community sentiment highlights strong enterprise AI server demand and a massive order backlog, skeptical traders are actively debating whether the current price action is sustainable or if the stock is vulnerable to a reversal after being heavily utilized as a high-visibility political catalyst.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as investors monitor reports of Japanese government interest in Greenland's rare earth mining opportunities, which could bolster the long-term strategic value of the company's Tanbreez project. Community discussions are centered on ongoing drilling progress, the upcoming merger with European Lithium, and debates regarding the company's valuation metrics and development timelines.

Cava Group, Inc. is a holding company, which engages in the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. It operates through the following segments: CAVA and CAVA Foods. The CAVA segment includes the operations of all company-owned CAVA restaurants. The CAVA Foods segment includes the production of dips and spreads used in CAVA restaurants as well as sales from the consumer-packaged goods (CPG) business. The company was founded by Brett Schulman, Ike Grigoropoulus, Dimitri Moshovitis, and Theodore Xenohristos in 2010 and is headquartered in Washington, DC.

Cava Group Inc

CAVA Group Inc

CAVA is experiencing heightened volatility and mixed sentiment as investors debate its premium valuation versus strong growth metrics, including impressive same-store sales and foot traffic. While some market participants are taking profits following the stock's rapid appreciation, others view the recent price consolidation as a strategic entry point, citing the company's successful national expansion and lack of debt as long-term competitive advantages.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRISPR Therapeutics is trending following the announcement of a $550 million convertible senior notes offering, which triggered short-term volatility as the market weighed the capital raise against the company's existing cash position. Investors are actively discussing the long-term strategic implications of this funding, while technical traders focus on critical support levels following the sharp move lower.

Datadog, Inc. engages in the development of a monitoring and analytics platform for developers, information technology operations teams and business users. Its platform integrates and automates infrastructure monitoring, application performance monitoring and log management to provide real-time observability of its customers' entire technology stack. The company was founded by Olivier Pomel and Alexis Lê-Quôc on June 4, 2010 and is headquartered in New York, NY.

Datadog Inc - Ordinary Shares - Class A

Datadog Inc

Datadog is attracting significant investor attention as analysts upgrade the stock, citing strong demand for its AI-native observability tools and enterprise infrastructure. The community remains focused on the company's ability to maintain growth despite broader software sector volatility, with many traders closely monitoring its performance as a key bellwether for AI-driven software monetization.

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Legend Biotech Corp - ADR

Legend Biotech

Legend Biotech is facing significant downward pressure and investor frustration following a disappointing earnings miss on its flagship Carvykti therapy, with community members calling for leadership changes or an outright sale of the company. Despite the recent price slide, the broader community remains divided, as some argue the stock is deeply undervalued given its growth pipeline and profitability targets while others express skepticism over the company's ability to execute against increasing competition and J&J partnership constraints.

ROAM Token

ROAM is gaining significant community traction as a leading DePIN infrastructure project that integrates global eSIM and WiFi connectivity with an AI-native access layer. Investors are particularly focused on its transition from a pure connectivity network to an ecosystem that supports AI agents and autonomous devices, fueled by real-world adoption through World Cup campaigns and strategic expansion into physical AI infrastructure.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is trending as investors weigh the company's aggressive acquisition strategy, highlighted by the recent purchase of DZYNE Technologies, against significant dilution concerns and a challenging technical setup. While bulls point to a growing defense-focused backlog and strategic integration with major partners, the community remains divided over management's capital allocation and the stock's inability to hold momentum, with intense discussion surrounding potential accumulation zones versus continued downside pressure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is it Apt to Retain Haemonetics Stock in Your Portfolio for Now?

HAE's Plasma franchise and NexSys PCS momentum may support growth, but heavy debt and competitive pressure remain key concerns.

Haemonetics Updates Financial Reporting Segments

Haemonetics Updates Financial Reporting Segments Haemonetics Updates Financial Reporting Segments PR Newswire BOSTON, June 5, 2026 BOSTON, June 5, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to...

Haemonetics to Present at Goldman Sachs 47th Annual Global Healthcare Conference

Haemonetics to Present at Goldman Sachs 47th Annual Global Healthcare Conference Haemonetics to Present at Goldman Sachs 47th Annual Global Healthcare Conference PR Newswire BOSTON, June 2, 2026 BOSTON, June 2, 2026 /PRNewswire/ --Haemonetics Corporation (NYSE: HAE) announced that Chris Simon...

Haemonetics (HAE) Shares Cross Above 200 DMA

In trading on Friday, shares of Haemonetics Corp. (Symbol: HAE) crossed above their 200 day moving average of $62.24, changing hands as high as $65.84 per share. Haemonetics Corp. shares are currently trading up about 5.1% on the day. The chart below shows the one year perform...

Investing in Haemonetics (HAE)? Don't Miss Assessing Its International Revenue Trends

Examine the evolution of Haemonetics' (HAE) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.

Is the Options Market Predicting a Spike in Haemonetics Stock?

Investors need to pay close attention to GBTG stock based on the movements in the options market lately.

HAE Stock Gains on Q4 Earnings & Revenue Beat, Gross Margin Cut

Haemonetics beats Q4 EPS and revenue estimates, shares rise 1.4%, but gross margin falls 120 basis points as the company sets its FY27 growth outlook.

Haemonetics Q4 Earnings Call Highlights

Haemonetics Q4 Earnings Call Highlights...

Haemonetics (HAE) Q4 2026 Earnings Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Haemonetics (HAE) Reports Q4 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Haemonetics (HAE) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.

Haemonetics Corp.

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	$1.09	--	--	N/A
Q4 '25	$1.27	$1.29	1.36%	BEAT
Q3 '25	$1.29	$1.31	1.81%	BEAT
Q2 '25	$1.11	$1.27	14.44%	BEAT
Q1 '25	$1.01	$1.10	9.11%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

HAEHaemonetics Corp.

Upcoming Earnings: Q1 '26

Historical Earnings

Latest HAE News